Low-Dose Ibutilide Combined with Catheter Ablation of Persistent Atrial Fibrillation: Procedural Impact and Clinical Outcome.
Xue-Rong SunYing TianAshok ShahXian-Dong YinLiang ShiYan-Jiang WangXiao-Qing LiuMeleze HociniMichel HaissaguerreXin-Chun YangXing-Peng LiuPublished in: Cardiology research and practice (2019)
Administration of low-dose ibutilide during ablation of persistent AF may allow select patients wherein substrate ablation is not or minimally required to optimize procedural and clinical outcomes.
Keyphrases
- catheter ablation
- atrial fibrillation
- low dose
- left atrial
- left atrial appendage
- end stage renal disease
- oral anticoagulants
- high dose
- direct oral anticoagulants
- ejection fraction
- heart failure
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- percutaneous coronary intervention
- venous thromboembolism
- patient reported outcomes